Merck has a long-standing relationship with Personalis through collaborations on individualized therapies.
According to the report, Merck has expressed interest in Personalis, along with two other suitors.
Stocktwits could not immediately verify the report.
Shares of Personalis (PSNL) rose 5% after-hours on Thursday following rumors that the precision oncology company is exploring strategic options, including a potential sale, after receiving takeover interest from Merck & Co. (MRK) and at least two other parties.
https://finance.yahoo.com/markets/stocks/articles/why-psnl-stock-5-hours-232735296.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.